1. Home
  2. RMBS vs ASND Comparison

RMBS vs ASND Comparison

Compare RMBS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rambus Inc.

RMBS

Rambus Inc.

HOLD

Current Price

$147.03

Market Cap

15.7B

Sector

Technology

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$210.87

Market Cap

14.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBS
ASND
Founded
1990
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
14.5B
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
RMBS
ASND
Price
$147.03
$210.87
Analyst Decision
Buy
Strong Buy
Analyst Count
7
16
Target Price
$137.00
$281.50
AVG Volume (30 Days)
1.9M
532.4K
Earning Date
04-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
27.88
N/A
EPS
0.55
N/A
Revenue
$707,630,000.00
N/A
Revenue This Year
$16.01
$96.35
Revenue Next Year
$16.23
$44.91
P/E Ratio
$307.82
N/A
Revenue Growth
27.13
N/A
52 Week Low
$57.98
$161.09
52 Week High
$174.10
$250.74

Technical Indicators

Market Signals
Indicator
RMBS
ASND
Relative Strength Index (RSI) 51.96 33.76
Support Level $86.08 $190.56
Resistance Level $161.80 $218.88
Average True Range (ATR) 11.43 8.26
MACD 1.01 -3.26
Stochastic Oscillator 45.88 0.19

Price Performance

Historical Comparison
RMBS
ASND

About RMBS Rambus Inc.

Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: